Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2022 09:41 ET | Source: CinCor Pharma Inc

CinCor Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 22, 2022

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the...
March 03, 2022 09:15 ET | Source: CinCor Pharma Inc

CinCor Pharma to Present at the 32nd Annual Oppenheimer Healthcare Conference

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment...
January 13, 2022 08:00 ET | Source: CinCor Pharma Inc

CinCor Pharma Appoints June Lee to Its Board of Directors

BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the company’s Board of Directors. Dr. Lee...
January 06, 2022 23:26 ET | Source: CinCor Pharma Inc

CinCor Pharma Announces Pricing of Initial Public Offering

BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for...
January 03, 2022 07:30 ET | Source: CinCor Pharma Inc

CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock

BOSTON, Jan. 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of...